openPR Logo
Press release

Generic Drugs Market Forecast to Reach USD 615.72 Billion by 2030

Generic Drugs Market

Generic Drugs Market

๐†๐ž๐ง๐ž๐ซ๐ข๐œ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐๐จ๐ข๐ฌ๐ž๐ ๐Ÿ๐จ๐ซ ๐’๐ข๐ ๐ง๐ข๐Ÿ๐ข๐œ๐š๐ง๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก

The global generic drugs market is on a robust growth trajectory, with projections indicating a rise from USD 431.15 billion in 2023 to approximately USD 615.72 billion by 2030, reflecting a compound annual growth rate (CAGR) of 5.22% during the forecast period.

๐Š๐ž๐ฒ ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ ๐จ๐Ÿ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐„๐ฑ๐ฉ๐š๐ง๐ฌ๐ข๐จ๐ง

Several factors are propelling this growth:

๐‘ท๐’‚๐’•๐’†๐’๐’• ๐‘ฌ๐’™๐’‘๐’Š๐’“๐’‚๐’•๐’Š๐’๐’๐’”: The expiration of patents for numerous branded medications has opened avenues for generic drug manufacturers to introduce cost-effective alternatives, enhancing accessibility for patients worldwide.
๐‘น๐’Š๐’”๐’Š๐’๐’ˆ ๐‘ท๐’“๐’†๐’—๐’‚๐’๐’†๐’๐’„๐’† ๐’๐’‡ ๐‘ช๐’‰๐’“๐’๐’๐’Š๐’„ ๐‘ซ๐’Š๐’”๐’†๐’‚๐’”๐’†๐’”: The increasing incidence of chronic conditions such as cardiovascular diseases, diabetes, and respiratory disorders has escalated the demand for affordable treatment options, further driving the generic drugs market.
๐‘ฎ๐’๐’—๐’†๐’“๐’๐’Ž๐’†๐’๐’• ๐‘ฐ๐’๐’Š๐’•๐’Š๐’‚๐’•๐’Š๐’—๐’†๐’”:Many governments are implementing policies to reduce healthcare expenditures, promoting the use of generic drugs as a cost-effective solution.

๐†๐ซ๐š๐› ๐ฒ๐จ๐ฎ๐ซ ๐Ÿ๐ซ๐ž๐ž ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž ๐œ๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐ญ๐ก๐ข๐ฌ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐ญ๐จ๐๐š๐ฒ: https://www.maximizemarketresearch.com/request-sample/25900/

๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐š๐ง๐ ๐ƒ๐ž๐ฏ๐ž๐ฅ๐จ๐ฉ๐ฆ๐ž๐ง๐ญ๐ฌ

The generic drugs market is witnessing varied growth patterns and strategic developments across different regions:

๐™‚๐™š๐™ฃ๐™š๐™ง๐™ž๐™˜ ๐˜ฟ๐™ง๐™ช๐™œ๐™จ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ ๐™Š๐™ฅ๐™ฅ๐™ค๐™ง๐™ฉ๐™ช๐™ฃ๐™ž๐™ฉ๐™ž๐™š๐™จ ๐™ž๐™ฃ ๐™‘๐™ž๐™š๐™ฉ๐™ฃ๐™–๐™ข

Vietnam's pharmaceutical market is expanding, with a notable increase in the adoption of generic drugs. The government's efforts to enhance healthcare access and affordability have led to policies favoring generic medications, creating significant opportunities for market players.

๐™‚๐™š๐™ฃ๐™š๐™ง๐™ž๐™˜ ๐˜ฟ๐™ง๐™ช๐™œ๐™จ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ ๐™‚๐™ง๐™ค๐™ฌ๐™ฉ๐™ ๐™ž๐™ฃ ๐™๐™๐™–๐™ž๐™ก๐™–๐™ฃ๐™™

Thailand's healthcare system is experiencing a shift towards generic drugs, driven by initiatives to reduce healthcare costs and improve patient access to essential medicines. The Thai government's support for generic drug use is fostering market growth.

๐™‚๐™š๐™ฃ๐™š๐™ง๐™ž๐™˜ ๐˜ฟ๐™ง๐™ช๐™œ๐™จ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ ๐™๐™ง๐™š๐™ฃ๐™™๐™จ ๐™ž๐™ฃ ๐™…๐™–๐™ฅ๐™–๐™ฃ

Japan has been actively promoting the use of generic drugs to curb healthcare spending. The government's target to increase the generic drug utilization rate has led to a surge in generic drug prescriptions, indicating a positive trend in the market.

๐™‚๐™š๐™ฃ๐™š๐™ง๐™ž๐™˜ ๐˜ฟ๐™ง๐™ช๐™œ๐™จ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ ๐˜พ๐™ค๐™ฃ๐™จ๐™ค๐™ก๐™ž๐™™๐™–๐™ฉ๐™ž๐™ค๐™ฃ ๐™ž๐™ฃ ๐™Ž๐™ค๐™ช๐™ฉ๐™ ๐™†๐™ค๐™ง๐™š๐™–

South Korea's generic drugs market is witnessing consolidation, with mergers and acquisitions among local pharmaceutical companies aiming to enhance competitiveness and expand product portfolios. This trend is expected to strengthen the market's growth prospects.

๐™‚๐™š๐™ฃ๐™š๐™ง๐™ž๐™˜ ๐˜ฟ๐™ง๐™ช๐™œ๐™จ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ ๐™๐™ฅ๐™™๐™–๐™ฉ๐™ž๐™ค๐™ฃ ๐™ž๐™ฃ ๐™Ž๐™ž๐™ฃ๐™œ๐™–๐™ฅ๐™ค๐™ง๐™š

Singapore is updating its regulatory framework to streamline the approval process for generic drugs, encouraging market entry and competition. These regulatory enhancements are anticipated to boost the availability of generic medications in the country.

๐™‚๐™š๐™ฃ๐™š๐™ง๐™ž๐™˜ ๐˜ฟ๐™ง๐™ช๐™œ๐™จ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ ๐™‚๐™ง๐™ค๐™ฌ๐™ฉ๐™ ๐™ž๐™ฃ ๐™ฉ๐™๐™š ๐™๐™ฃ๐™ž๐™ฉ๐™š๐™™ ๐™Ž๐™ฉ๐™–๐™ฉ๐™š๐™จ

The U.S. generic drugs market remains robust, with significant contributions to healthcare cost savings. The high adoption rate of generic medications continues to drive market growth, supported by a favorable regulatory environment.

๐™‚๐™š๐™ฃ๐™š๐™ง๐™ž๐™˜ ๐˜ฟ๐™ง๐™ช๐™œ๐™จ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ ๐™๐™ง๐™š๐™ฃ๐™™๐™จ ๐™ž๐™ฃ ๐˜พ๐™๐™ž๐™ฃ๐™–

China's generic drugs market is expanding rapidly, driven by healthcare reforms and policies promoting the use of generics to make healthcare more affordable. The government's emphasis on generic drug quality and consistency is fostering market confidence and growth.

๐™‚๐™š๐™ฃ๐™š๐™ง๐™ž๐™˜ ๐˜ฟ๐™ง๐™ช๐™œ๐™จ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ ๐™Š๐™ฅ๐™ฅ๐™ค๐™ง๐™ฉ๐™ช๐™ฃ๐™ž๐™ฉ๐™ž๐™š๐™จ ๐™ž๐™ฃ ๐™€๐™ช๐™ง๐™ค๐™ฅ๐™š

Europe presents substantial opportunities for the generic drugs market, with increasing acceptance and integration of generic medications into healthcare systems. Efforts to harmonize regulations across the European Union are facilitating market expansion and accessibility.

๐™‚๐™š๐™ฃ๐™š๐™ง๐™ž๐™˜ ๐˜ฟ๐™ง๐™ช๐™œ๐™จ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ ๐™๐™š๐™˜๐™š๐™ฃ๐™ฉ ๐˜ฟ๐™š๐™ซ๐™š๐™ก๐™ค๐™ฅ๐™ข๐™š๐™ฃ๐™ฉ๐™จ

The generic drugs industry has witnessed significant mergers and acquisitions aimed at enhancing market reach and product offerings. For instance, in recent years, major pharmaceutical companies have engaged in strategic partnerships to strengthen their positions in the global market.

๐˜๐ž๐š๐ซ-๐„๐ง๐ ๐’๐š๐ฅ๐ž! ๐†๐ž๐ญ ๐ฎ๐ฉ ๐ญ๐จ ๐Ÿ‘๐ŸŽ% ๐จ๐Ÿ๐Ÿ ๐จ๐ง ๐œ๐จ๐ฆ๐ฉ๐ซ๐ž๐ก๐ž๐ง๐ฌ๐ข๐ฏ๐ž ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ซ๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ-๐ฅ๐ข๐ฆ๐ข๐ญ๐ž๐ ๐ญ๐ข๐ฆ๐ž ๐จ๐ง๐ฅ๐ฒ: https://www.maximizemarketresearch.com/request-sample/25900/

๐†๐ž๐ง๐ž๐ซ๐ข๐œ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ:

๐›๐ฒ ๐๐ซ๐จ๐๐ฎ๐œ๐ญ

Simple Generics
Super Generics
Biosimilars

The global generic drug industry is divided into three segments based on the product: biosimilars, super generics, and simple generics. In 2023, the Super Generics category had the biggest market share, with about 38%. Super generic medications are referred to as value enhanced generics, hybrids, and unique therapeutic entities. Super generic products are not the same as the original product in terms of composition or distribution method. Although biosimilars can only be as comparable to the original branded drug as validation technology allows, they have the same clinical impact as generics. As biosimilar developers concentrate on increasingly complicated proteins that require more expensive and advanced production processes, they will be pressured to follow established methods for demonstrating a high degree of similarity.

๐›๐ฒ ๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง

Cardiovascular Products
Anti-Infective Drugs
Anti-Arthritis Drugs
Central Nervous System Drugs
Anti-Cancer Drug
Respiratory Products
Others

Cardiovascular Products, Anti-Infective Drugs, Anti-Arthritis Drugs, Central Nervous System Drugs, Anti-Cancer Drugs, Respiratory Products, and Others are the sub-segments of the worldwide generic drug market based on application. In 2023, the biggest market share was held by the Central Nervous System Drugs sector. Access to better healthcare options, societal acceptance of people with mental illnesses, and growing knowledge of mental health issues are some of the key factors predicted to propel market expansion. The expansion of the generic medication market is anticipated to be driven by affordable and easily accessible pharmaceuticals during the forecast period.

๐›๐ฒ ๐ƒ๐ข๐ฌ๐ญ๐ซ๐ข๐›๐ฎ๐ญ๐ข๐จ๐ง ๐‚๐ก๐š๐ง๐ง๐ž๐ฅ

Hospitals
Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
Others

๐“๐จ ๐š๐œ๐œ๐ž๐ฌ๐ฌ ๐ฆ๐จ๐ซ๐ž ๐๐ž๐ญ๐š๐ข๐ฅ๐ฌ ๐ซ๐ž๐ ๐š๐ซ๐๐ข๐ง๐  ๐ญ๐ก๐ข๐ฌ ๐ซ๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก, ๐ฏ๐ข๐ฌ๐ข๐ญ ๐ญ๐ก๐ž ๐Ÿ๐จ๐ฅ๐ฅ๐จ๐ฐ๐ข๐ง๐  ๐ฐ๐ž๐›๐ฉ๐š๐ ๐ž: https://www.maximizemarketresearch.com/request-sample/25900/

๐†๐ž๐ง๐ž๐ซ๐ข๐œ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ:

North America Generic Drugs Market Top Players:

1. Mylan N.V. - (USA)
2. Par Pharmaceuticals- (USA)
3. Pfizer - (USA)
4. Baxter International Inc. - (USA)
5. Eli Lilly and Company - (USA)
6. Abbott Laboratories - (USA)
7. Apotex Inc. - (Canada)
8. Apotex Corp. - (USA)

Europe Generic Drugs Market Top Players

1. Endo Pharmaceuticals - (Ireland)
2. Teva Pharmaceutical Industries Ltd- (Israel)
3. STADA Arzneimittel AG - (Germany)
4. GlaxoSmithKline Plc. - (United Kingdom)
5. Novartis International AG - (Switzerland)

APAC Generic Drugs Market Top Players:

1. Sun Pharma - (India)
2. Lupin Pharmaceuticals - (India)
3. Dr Reddy's - (India)
4. ASKA Pharmaceutical Co., Ltd. - (Japan)
5. Taisho Pharmaceutical Holdings Co Ltd - (Japan)
6. Aurobindo Pharma Limited - (India)
7. Hikma Pharmaceuticals PLC - (Jordan)
8. Torrent Pharmaceuticals Ltd - (India)

๐’๐ญ๐š๐ฒ ๐š๐ก๐ž๐š๐ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐œ๐ฎ๐ซ๐ฏ๐ž ๐ฐ๐ข๐ญ๐ก ๐ญ๐ก๐ž ๐ญ๐ซ๐ž๐ง๐๐ข๐ง๐  ๐ซ๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐Ÿ๐ซ๐จ๐ฆ ๐Œ๐š๐ฑ๐ข๐ฆ๐ข๐ณ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:

Global Processed Mango Product Market https://www.maximizemarketresearch.com/market-report/global-processed-mango-product-market/42767/

Global Zircon Sand Market https://www.maximizemarketresearch.com/market-report/global-zircon-sand-market/89123/

Global Magnetic Separator Market https://www.maximizemarketresearch.com/market-report/global-magnetic-separator-market/116659/

Global Active Hemostatic Agents Market https://www.maximizemarketresearch.com/market-report/global-active-hemostatic-agents-market/97666/

Global Filter Bag Market https://www.maximizemarketresearch.com/market-report/global-filter-bag-market/36299/

Global Phosphate Ester Market https://www.maximizemarketresearch.com/market-report/phosphate-ester-market/2600/

Global Audio Interface Market https://www.maximizemarketresearch.com/market-report/global-audio-interface-market/66820/

Global Robot Cars and Trucks Market https://www.maximizemarketresearch.com/market-report/global-robot-cars-and-trucks-market/19646/

Composite Rebar Market https://www.maximizemarketresearch.com/market-report/composite-rebar-market/218967/

Polymer Fillers Market https://www.maximizemarketresearch.com/market-report/polymer-fillers-market/147129/

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ:

MAXIMIZE MARKET RESEARCH PVT. LTD.
3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
+91 9607365656
sales@maximizemarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Generic Drugs Market Forecast to Reach USD 615.72 Billion by 2030 here

News-ID: 3809953 • Views: โ€ฆ

More Releases from Maximize Market Research Pvt. Ltd.

Automotive Telematics Insurance Market to Surge to USD 331.86 Billion by 2032, Fueled by a 15.96% CAGR
Automotive Telematics Insurance Market to Surge to USD 331.86 Billion by 2032, F โ€ฆ
Automotive Telematics Insurance Market size was valued at USD 101.50 Billion in 2024 and the total Automotive Telematics Insurance revenue is expected to grow at a CAGR of 15.96% from 2025 to 2032, reaching nearly USD 331.86 Billion. Automotive Telematics Insurance Market Overview: The Automotive Telematics Insurance Market, often referred to as Usage-Based Insurance (UBI), represents the convergence of telecommunications and informatics within the auto insurance sector. This market revolves around theโ€ฆ
Artificial Intelligence in Agriculture Market to Grow at a Stellar 21.5% CAGR, Targeting US$ 7.88 Bn by 2030
Artificial Intelligence in Agriculture Market to Grow at a Stellar 21.5% CAGR, T โ€ฆ
Artificial Intelligence in Agriculture Market size is expected to grow at 21.5% throughout the forecast period, reaching nearly US$ 7.88 Bn by 2030 Artificial Intelligence in Agriculture Market Overview: The Artificial Intelligence in Agriculture market represents the integration of advanced computational technologies into farming practices to enhance efficiency, productivity, and sustainability. This market encompasses a wide array of solutions, including predictive analytics for crop yield forecasting, computer vision systems for monitoring plantโ€ฆ
Offshore Support Vessels Market to Reach USD 4.16 Billion by 2032, Growing at a 6.5% CAGR
Offshore Support Vessels Market to Reach USD 4.16 Billion by 2032, Growing at a โ€ฆ
Offshore Support Vessels Market size was valued at USD 2510.79 Million in 2024 and the total Offshore Support Vessels revenue is expected to grow at a CAGR of 6.5% from 2025 to 2032, reaching nearly USD 4155.34 Million. Offshore Support Vessels Industry Overview: The offshore support vessels (OSV) industry provides a critical maritime logistical backbone for offshore oil and gas exploration and production activities, as well as a growing role in offshoreโ€ฆ
Commercial Vehicles Market Forecast to Expand from USD 848.63 Billion to USD 1.23 Trillion by 2032
Commercial Vehicles Market Forecast to Expand from USD 848.63 Billion to USD 1.2 โ€ฆ
Commercial Vehicles Market size was valued at USD 848.63 Billion in 2024 and the total Commercial Vehicles revenue is expected to grow at a CAGR of 4.7% from 2025 to 2032, reaching nearly USD 1225.45 Billion. Commercial Vehicles Market Overview: The commercial vehicles market is a vital segment of the global automotive industry, encompassing vehicles designed primarily for transporting goods or passengers for commercial purposes. This broad category includes light commercial vehiclesโ€ฆ

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcomingโ€ฆ
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De โ€ฆ
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeuticโ€ฆ
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric โ€ฆ
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550โ€ฆ
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application โ€ฆ
Market Study Report, LLC, has compiled an exhaustive research study of the โ€˜Alcohol Testing And Drug Testing Equipment marketโ€™, detailing every single market driver and intricately analyzing the business vertical. This โ€˜Alcohol Testing And Drug Testing Equipment marketโ€™ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drugโ€ฆ
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drugย Marketย From an insight perspective, the market report focuses on various levels of analyses โ€” industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.ย  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetesโ€ฆ
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymeraseโ€ฆ